Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02017379Terminated
Randomised trial of erythromycin and metoclopramide in upper gastrointestinal bleeding (UGIB) (3 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoints: Erythromycin, Metoclopromide vs Control Enabling Visualization of the Entire Gastric Mucosa at 45 minutes and Erythromycin, Metoclopromide vs Control Improving the Quality of Stomach and Duodenum Visualization at 45 minutes. Started Jun 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02017379.